Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Total Current Liabilities (2016 - 2025)

Neuroone Medical Technologies' Total Current Liabilities history spans 14 years, with the latest figure at $1.3 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities fell 19.89% year-over-year to $1.3 million; the TTM value through Dec 2025 reached $1.3 million, down 19.89%, while the annual FY2025 figure was $2.3 million, 4.06% up from the prior year.
  • Total Current Liabilities reached $1.3 million in Q4 2025 per NMTC's latest filing, down from $2.3 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $3.1 million in Q3 2022 to a low of $746852.0 in Q2 2021.
  • Average Total Current Liabilities over 5 years is $1.5 million, with a median of $1.5 million recorded in 2024.
  • Peak YoY movement for Total Current Liabilities: crashed 82.82% in 2021, then surged 162.22% in 2022.
  • A 5-year view of Total Current Liabilities shows it stood at $1.1 million in 2021, then increased by 25.64% to $1.3 million in 2022, then rose by 3.63% to $1.4 million in 2023, then increased by 13.57% to $1.6 million in 2024, then decreased by 19.89% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for NMTC's Total Current Liabilities are $1.3 million (Q4 2025), $2.3 million (Q3 2025), and $1.4 million (Q2 2025).